The clinical benefits of finerenone on cardiovascular and kidney events are also unlikely affected by combination therapy with GLP-1RA or SGLT2i, however, clinical evidence on additive effects of finerenone in combination with GLP-1RA or SGLT2i are still limited [56, 57]
Dermatologic findings associated with semaglutide use: A scoping review [PMID: 38554940] Laboratory literature summary: Dermatologic findings associated with semaglutide use: A scoping review
Macronutrients, bile acids (BAs), and microbiota-derived compounds activate many of these GPCRs expressed by GLP-1 expressing cells ( The main G protein-coupled receptors which activation appears to cause the release of GLP-1 are: GPRC6A (74), Tas1R2-Tas2R3(T1R2-T1R3) (75), GPBAR1 (TGR5), and CasR (76, 77) (Table 1)
According to functional magnetic resonance imaging, anticipatory food reward the anticipated pleasure of eating certain meals is reduced when GLP- 1 R is activated [110, 111]
Cardio is the second priority, not the first